By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



Corporate Headquarters
One Amgen Center Drive
Thousand Oaks  California  91320-1789  U.S.A.
Phone: 805-447-1000 Fax: 805-447-1010


Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.

Amgen focuses on areas of high unmet medical need and leverages its biologics manufacturing expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.

For more information, visit, LinkedIn and follow us on


Key Statistics

Ownership: Public

Web Site: Amgen
Employees: 20,000
Symbol: AMGN

Company News
Amgen (AMGN) Wins European Commission (EC) Approval for Repatha Single-Dose Delivery Option 2/22/2017 6:19:23 AM
Genentech (RHHBY) Fighting to Delay Amgen (AMGN)'s Avastin Biosimilar 2/17/2017 6:54:52 AM
Amgen (AMGN)’s Repatha CVOT Results Are Potential Game-Changer For Lipid-Lowering Treatment 2/16/2017 7:07:48 AM
Amgen (AMGN)’s Repatha CVOT Results Are Potential Game-Changer For Lipid-Lowering Treatment 2/15/2017 8:47:24 AM
Amgen (AMGN) Submits Supplemental Biologics License Application For BLINCYTO (Blinatumomab) In Relapsed Or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia 2/14/2017 7:13:45 AM
FDA Approves Amgen (AMGN)'s Parsabiv (Etelcalcetide), First New Treatment In More Than A Decade For Secondary Hyperparathyroidism In Adult Patients On Hemodialysis 2/8/2017 7:00:46 AM
Amgen (AMGN) Announces Appointment Of Charles M. Holley Jr. To Board Of Directors 2/6/2017 6:39:42 AM
Amgen (AMGN)'s Repatha Will Test The New Drug Pricing Reality 2/6/2017 5:59:06 AM
Amgen (AMGN) Reports Fourth Quarter And Full Year 2016 Financial Results 2/3/2017 11:52:06 AM
A Look at the Types of Jobs Amgen (AMGN)'s Promise to Trump Will Bring 2/3/2017 5:39:58 AM